STEVEN BOYD

Corporate Board Profile

Tech Score: 0/100

TENAX THERAPEUTICS, INC.

Filing Date	Source Excerpt
2021-04-30	Steven Boyd has served as a director since July 2020. Mr. Boyd has served since 2012 as the chief investment officer of Armistice Capital, LLC ("Armistice"), a long-short equity hedge fund focused on the health care and consumer sectors.
2022-04-28	Steven Boyd has served as a director since July 2020. Our Board of Directors believes that Mr. Boyd’s experience in capital markets and strategic transactions, and his focus on the healthcare industry makes him a valuable member of our Board. The Board has determined that Mr. Boyd is an independent director. Mr. Boyd has agreed not to receive compensation for his service as a member of the Board of Directors in light of his position with Armistice Capital, LLC.

Filing Date

Source Excerpt

2021-04-30

Steven Boyd has served as a director since July 2020. Mr. Boyd has served since 2012 as the chief investment officer of Armistice Capital, LLC ("Armistice"), a long-short equity hedge fund focused on the health care and consumer sectors.

2022-04-28

Steven Boyd has served as a director since July 2020. Our Board of Directors believes that Mr. Boyd’s experience in capital markets and strategic transactions, and his focus on the healthcare industry makes him a valuable member of our Board. The Board has determined that Mr. Boyd is an independent director. Mr. Boyd has agreed not to receive compensation for his service as a member of the Board of Directors in light of his position with Armistice Capital, LLC.

Vaxart, Inc.

Filing Date	Source Excerpt
2020-04-24	Steven Boyd has served as a director since October 2019.

Data sourced from SEC filings. Last updated: 2025-07-01